Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Celadon Pharmaceuticals PLC reported significant operational and strategic progress in its latest unaudited interim results, including a strategic collaboration with Valeos Pharma A/S to enhance European supply capabilities and the completion of 12 harvests. Despite operational successes, the company faced delays due to funding issues but remains optimistic about fulfilling significant supply requests for its EU-GMP cannabis products. Financially, Celadon showed an increase in revenue to £63k and managed to reduce its operating loss compared to the previous year, with expectations of further progress upon securing anticipated funding.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
